Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib

Royal Society of Chemistry (RSC) - Tập 8 Số 1 - Trang 96-102
Viktoria von Manstein1,2,3,4, Bernd Groner1,2,3,4
160596 Frankfurt am Main
2Georg Speyer Haus, Institute for Tumor Biology and Experimental Therapy, Paul Ehrlich Str. 42, 60596 Frankfurt am Main, Germany
3Germany
4Institute for Tumor Biology and Experimental Therapy

Tóm tắt

Tumor cell resistance to drug treatment severely limits the therapeutic success of treatment.

Từ khóa


Tài liệu tham khảo

Haber, 2011, Cell, 145, 19, 10.1016/j.cell.2011.03.026

Iorio, 2016, Cell, 166, 740, 10.1016/j.cell.2016.06.017

Settleman, 2016, Cell, 164, 1101, 10.1016/j.cell.2016.02.050

Holohan, 2013, Nat. Rev. Cancer., 13, 714, 10.1038/nrc3599

Baguley, 2016, Methods Mol. Biol., 1395, 19, 10.1007/978-1-4939-3347-1_2

Rueff, 2016, Methods Mol. Biol., 1395, 1, 10.1007/978-1-4939-3347-1_1

Lito, 2012, Cancer Cell, 22, 668, 10.1016/j.ccr.2012.10.009

Lito, 2013, Nat. Med., 19, 1401, 10.1038/nm.3392

Cojoc, 2015, Semin. Cancer Biol., 31, 16, 10.1016/j.semcancer.2014.06.004

Lee, 2014, Cancer Cell, 26, 207, 10.1016/j.ccr.2014.05.019

Zhao, 2016, Trends Pharmacol. Sci., 37, 47, 10.1016/j.tips.2015.10.001

Britschgi, 2012, Cancer Cell, 22, 796, 10.1016/j.ccr.2012.10.023

Ramos, 2015, Oncogene, 34, 3617, 10.1038/onc.2014.314

Eichten, 2016, Cancer Res., 76, 2327, 10.1158/0008-5472.CAN-15-1443

Tan, 2014, Curr. Drug Targets, 15, 1341, 10.2174/1389450115666141120104146

Yu, 2014, Nat. Rev. Cancer, 14, 736, 10.1038/nrc3818

Groner, 2012, Horm. Mol. Biol. Clin. Invest., 10, 193

Groner, 2012, JAKSTAT, 1, 211

Poli, 2015, Front Oncol., 5, 121, 10.3389/fonc.2015.00121

Wake, 2015, FEBS J., 282, 2600, 10.1111/febs.13285

Arulanandam, 2010, Exp. Cell Res., 316, 875, 10.1016/j.yexcr.2009.10.017

Geletu, 2013, Biochim. Biophys. Acta, 1833, 1947, 10.1016/j.bbamcr.2013.03.014

Smilowitz, 2007, J. Neurosurg., 106, 652, 10.3171/jns.2007.106.4.652

Priester, 2013, Neuro Oncol., 15, 840, 10.1093/neuonc/not025

Jarboe, 2013, Recent Pat. Anti-Cancer Drug Discovery, 8, 228, 10.2174/15748928113089990043

Djerf Severinsson, 2011, Biochem. Biophys. Res. Commun., 414, 563, 10.1016/j.bbrc.2011.09.118

Tang, 2015, Hear Res., 328, 59, 10.1016/j.heares.2015.07.002

von Manstein, 2016, J. Drug Des. Res., 3, 1026

von Manstein, 2013, Curr. Signal Transduction Ther., 8, 193, 10.2174/1574362409666140206221931

Anagnostopoulou, 2006, Cancer Lett., 242, 120, 10.1016/j.canlet.2005.10.047

Raptis, 2009, Biochem. Cell Biol., 87, 835, 10.1139/O09-061

Raptis, 2011, Exp. Cell Res., 317, 1787, 10.1016/j.yexcr.2011.05.008

Niit, 2015, Biomol Concepts., 6, 383, 10.1515/bmc-2015-0022

Pohl, 1999, Int. J. Oncol., 15, 829